Cargando…
Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases
BACKGROUND: Immune checkpoint inhibitor (ICI) induced myocarditis is a rare, severe, and often fatal adverse event. Evidence to guide appropriate immunosuppressive therapy is scarce. We present a case of ICI-induced myocarditis and a review of ICI-induced myocarditis cases to determine the most effe...
Autores principales: | Matzen, Emma, Bartels, Lars Erik, Løgstrup, Brian, Horskær, Stine, Stilling, Christina, Donskov, Frede |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351114/ https://www.ncbi.nlm.nih.gov/pubmed/34365980 http://dx.doi.org/10.1186/s40959-021-00114-x |
Ejemplares similares
-
Immune checkpoint inhibitor–associated myocarditis: Case reports and a review of the literature
por: Osinga, T. E., et al.
Publicado: (2022) -
Immune Checkpoint Inhibitors-Related Myocarditis: A Review of Reported Clinical Cases
por: Zotova, Liudmila
Publicado: (2023) -
Immune checkpoint inhibitor–associated myocarditis: a systematic analysis of case reports
por: Wang, Caie, et al.
Publicado: (2023) -
Fulminant myocarditis caused by immune checkpoint inhibitor: a case report and possible treatment inspiration
por: Liu, Zhijie, et al.
Publicado: (2022) -
Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
por: Wang, Feifei, et al.
Publicado: (2021)